Merck Texas inquiry
Executive Summary
Merck receives civil investigative demand from Texas attorney general seeking the "documents and other information regarding the company's marketing and selling activities relating to Texas," 1Merck's 10-K filing with SEC March 10 says. Record-keeping at Medco's Dallas/Fort Worth mail-order facility is the subject of an investigation by the Philadelphia U.S. Attorney's Office (2"The Pink Sheet" Oct. 6, 2003, p. 36). Medco was spun off by Merck in July...
You may also be interested in...
Medco SEC Filing For Spin-Off Included “False Statement” On Audit – DoJ Suit
Medco's disclosure of record-keeping problems discovered at its Dallas/Fort Worth pharmacy in an SEC filing included a "false statement," the Philadelphia U.S. Attorney alleges in a complaint filed against the pharmacy benefit management company Sept. 29
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.